WENDI HANNA: Open Payments
NPI 1346758257 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 74 payments from 29 companies in 2025. Trend: 2023 $2,099 · 2024 $2,761 · 2025 $1,586
Food & beverage: $1,402Education: $184
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $211 |
| Novartis Pharmaceuticals Corporation | 7 | $137 |
| PFIZER INC. | 7 | $112 |
| SEAGEN INC. | 1 | $100 |
| Astellas Pharma US Inc | 3 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $80 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| Daiichi Sankyo Inc. | 3 | $57 |
Products named: RYBREVANT, KISQALI, REBLOZYL, DARZALEX, KEYTRUDA, Vyloy, ZEJULA, XTANDI.
Industry payments across KY — which companies pay providers there.
